Based on the Fuse Medical Inc stock forecast from 0 analysts, the average analyst target price for Fuse Medical Inc is not available over the next 12 months. Fuse Medical Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Fuse Medical Inc is Slightly Bullish , which is based on 6 positive signals and 5 negative signals. At the last closing, Fuse Medical Inc’s stock price was USD 0.1. Fuse Medical Inc’s stock price has changed by +0.00% over the past week, -16.67% over the past month and +150.00% over the last year.
No recent analyst target price found for Fuse Medical Inc
No recent average analyst rating found for Fuse Medical Inc
Company Overview Fuse Medical Inc
Fuse Medical, Inc. manufactures and distributes medical devices in the United States. The company offers orthopedic implants, including internal and external fixation products for foot and ankle; upper and lower extremity plating and total joint reconstruction implants; soft tissue fixation and augmentation for sports medicine procedures; and full spinal implants for trauma, degenerative disc disease, and deformity indications. It also provides osteo-biologics and regenerative products, which include human allografts, tendons, synthetic skin and bone substitute materials, and regenerative tissues. The company serves hospitals, medical facilities, and sub-distributors. Fuse Medical, Inc. is based in Richardson, Texas. Read Less
Fuse Medical, Inc. manufactures and distributes medical devices in the United States. The company offers orthopedic implants, including internal and external fixation products for foot and ankle; upper and lower extremity plating and total joint reconstruction implants; soft tiss...Read More
Frequently Asked Questions About Fuse Medical Inc (FZMD) Stock
Stock Target Advisor's fundamental analysis for Fuse Medical Inc's stock is Slightly Bullish .
Unfortunately we do not have enough data on FZMD's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on FZMD's stock to indicate what its average analyst target is.
FZMD stock's Price/Earning ratio is 1.98.
Our analysis grades FZMD stock's Price / Earning ratio at C+. This means that FZMD stock's Price/Earning ratio is above 22% of the stocks in the Medical Devices sector in the OTC exchange.
Based on this FZMD may be undervalued for its sector.
The last closing price of FZMD's stock was USD 0.10.
The most recent market capitalization for FZMD is USD 7.30M.
Unfortunately we do not have enough analyst data on FZMD's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Fuse Medical Inc's stock.
As per our most recent records Fuse Medical Inc has 0 Employees.
Fuse Medical Inc's registered address is 1565 North Central Expressway, Richardson, TX, United States, 75080.
You can get more information about it from Fuse Medical Inc's website at https://www.fusemedical.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for FZMD !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
